Value of medical writing: The regulatory writer's perspective - Volume 31, Issue

The American Medical Writers Association formed a working group in 2020 focused on understanding and communicating the value that regulatory medical writers contribute to project teams, companies, and the wider research community. The working…

Medical Communications and Writing for Patients - Volume 31, Issue

In this issue, the Medical Communications and Writing for Patients section features two articles. The first piece, by Simon Linacre,  is a summary of the excellent work just completed by the Med Comms SIG. They have devised, run, and collated the res…

Home office: Yay or nay? - Volume 31, Issue

In the first quarter of 2022, Bioforum performed an anonymous internal survey among its medical writers to understand if our employees would like to return to a physical office or prefer to stay in the home office despite the lifting of most of the…

The worldwide landscape of freelance medical writing: Exploring challenges and opportunities - Volume 33, Issue

The COVID-19 pandemic has had a significant impact on the pharmaceutical, biotechnology, and life sciences industries, ultimately affecting associated professionals such as freelance medical writers. Throughout this global event and its aftermath,…

Post-market clinical follow-up insights - Volume 31, Issue

The EU Medical Devices Regulation (MDR) brought about new post-market clinical follow-up (PMCF) requirements for medical devices. Whereas complaint monitoring and literature searches were often sufficient under the Medical Devices Directives (MDD),…

Can readers spot the AI impostor in healthcare writing? - Volume 32, Issue

The use of artificial intelligence (AI) writing assistants in the healthcare industry is becoming increasingly prevalent. These tools can help medical writers to generate content more quickly and efficiently, but they also raise concerns about the…

Optimizing the value of regulatory writers - Volume 31, Issue

An expanding need for clinical documentation and regulatory health authority interactions during drug development has drawn increased attention to the role of the regulatory medical writer. This role is frequently misunderstood and poorly…

Writing for lay audiences - Volume 24, Issue

For most of us, medical writing is highly technical. We prepare regulatory or clinical documents or write materials targeted to medical doctors. Medical writing for lay audiences is different, and it does not come naturally to most of us because…

EMWA news - Volume 21, Issue

News from the EMWA Website Manager   New role At the recent EMWA conference held in Cyprus, I assumed the position of EMWA Website Manager. While this is a daunting task, it is a challenge I am pleased to take on. To ensure that I was in a…

Martin Harvey